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Protein–lipid interactionApolipoproteins are essential human proteins for lipidmetabolism. Together with phospholipids, they constitute
lipoproteins, nm to μm sized particles responsible for transporting cholesterol and triglycerides throughout the
body. To investigate speciﬁc protein–lipid interactions, we produced and characterized three single-Trp contain-
ing apolipoprotein C-III (ApoCIII) variants (W42 (W54F/W65F),W54 (W42F/W65F),W65 (W42F/W54F)). Upon
binding to phospholipid vesicles, wild-type ApoCIII adopts an α-helical conformation (50% helicity) as deter-
mined by circular dichroism spectroscopy with an approximate apparent partition constant of 3 × 104 M−1.
Steady-state and time-resolved ﬂuorescence measurements reveal distinct residue-speciﬁc behaviors with
W54 experiencing the most hydrophobic environment followed by W42 and W65. Interestingly, time-resolved
anisotropy measurements show a converse trend for relative Trp mobility with position 54 being the least
immobile. To determine the relative insertion depths of W42, W54, and W65 in the bilayer, ﬂuorescence
quenching experiments were performed using three different brominated lipids. W65 had a clear preference
for residing near the headgroupwhileW54 andW42 sample the range of depths ~8–11Å from the bilayer center.
On average, W54 is slightly more embedded than W42. Based on Trp spectral differences between ApoCIII
binding to phospholipid vesicles and sodiumdodecyl sulfatemicelles,we suggest that ApoCIII adopts an alternate
helical conformation on the bilayer which could have functional implications.
Published by Elsevier B.V.1. Introduction
Hypertriglyceridemia is a prevalent lipid metabolism disorder
where plasma triglyceride levels are elevated and can lead to the
onset of atherosclerosis, cardiovascular disease, insulin resistance, and
type II diabetes [1]. While detailed molecular mechanisms remain
unclear, overexpression of apolipoprotein C-III (ApoCIII) has been
correlated to increased concentrations of triglyceride and linked to
cardiovascular disease risk [2–4]. Modulation of ApoCIII levels is being
pursued as a novel therapeutic approach to reduce plasma triglycerides
[5]. ApoCIII is a small 79 amino acid, amniote-speciﬁc protein rich in
Ser and Ala (Fig. 1A) that together with other apolipoproteins andCII, apolipoprotein C-II; SDS,
-glycero-3-phosphocholine;
, circular dichroism; Br6–7PC,
hosphocholine; Br9–10PC, 1-
hosphocholine; Br11–12PC, 1-
phocholine; NATA, N-acetyl-
ethane; WT, wild-type; L/P,
artition constant; λmax, peak
sphatidylcholine; ro, initial an-
isotropy; Γ, spectral width.phospholipids form lipoprotein particles responsible for the transport
of cholesterol and triglycerides throughout the body. Common lipopro-
teins include high-density, low-density, and very-low-density lipopro-
teins as well as chylomicrons. Lipoproteins vary greatly in size
(~nm–μm) and in the relative concentrations of phospholipids, triglyc-
erides, and cholesterol. Importantly, ApoCIII is an exchangeable apolipo-
protein that moves from one lipoprotein to another [6,7]. One proposed
mechanism by which ApoCIII promotes hypertriglyceridemia is by
inhibiting a lipoprotein lipase, triacylglycerol hydrolase, from
interacting with the lipoprotein [7–9]. On the other hand, ApoCIII may
also displace other enzyme activating apolipoproteins, such as apolipo-
protein C-II (ApoCII) from the lipoprotein surface [10,11]. Despite the
importance of ApoCIII [7,12–15], fundamental understanding of its
phospholipid binding properties remains limited.
In solution, ApoCIII is unstructured. However, based on primary
sequence analysis the protein is predicted to adopt an α-helical confor-
mation upon membrane association [18]. Both N- and C-terminal
portions of ApoCIII have been shown to interact with lipids [14,15,19,
20]. A structural study by Gangabadage et al.[16] on the sodium dodecyl
sulfate (SDS) micelle bound form of ApoCIII clearly demonstrated that
the protein becomes helical with the formation of amphipathic helices
connected by semiﬂexible hinges and linkers (Fig. 1B). Both favorable
hydrophobic and electrostatic interactions with the micelle are found.
Fig. 1. (A) Primary sequence of ApoCIII is shown with tryptophan sites, W42, W54, and
W65 used in this study colored red, green, and blue, respectively. Acidic and basic
amino acids are colored pink and cyan, respectively. The overall charge of the protein is
−4 at neutral pH and the calculated pI is 4.72 using ProtParam Program (http://web.
expasy.org/protparam/). The underlined helical regions are based on the SDS-bound
protein structure determined fromNMR spectroscopy (PDB ID: 2JQ3[16]). (B) SDS-micelle
bound structure of ApoCIII is shown with the three native tryptophan residues indicated.
(C) Analysis of the hydrophobicity distribution along the sequence using the MPEx web
tool (http://blanco.biomol.uci.edu/mpex/). The Wimley–White Interfacial (IF) scale [17]
and a window size of 5 amino acids were used. Hydropathy predicted regions are
shown as cyan lines (8–15, 26–30, 40–44, 46–57, 61–68) and for comparison, helices
based on the NMR 3-dimensional structure are shown as black lines. W42, W54, and
W65 all reside in putative hydropathy regionswithW54 as themost favorable to partition
into bilayer from water.
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Lys residues at the polar–nonpolar interface and negatively charged
carboxylic acids at the polar face and G* (helices 1, 2, 3, and 5) with
randomly distributed positive and negative residues somewhat similar
to those found in globular proteins [19,21]. While the SDS micelle-
bound structure provides invaluable insights, phospholipids are
required for the proper folding and function of apolipoproteins [19,22,
23] and micelles are not suitable mimics for the much larger lipopro-
teins. Indeed, the observed curved helices may only be present to
accommodate the highly curvedmicelle surface. Moreover, the location
or presence of the hinges (or breaks in the helices) and linkers likely are
differentwhen bound to larger particles. To obtain a complete picture of
membrane binding properties of ApoCIII, the use of other membrane
models and phospholipids is necessary.
We have employed ~100 nm diameter phospholipid vesicles con-
taining equimolar phosphatidylcholine and phosphatidic acid (PC/PA)to characterize the membrane partitioning equilibrium of ApoCIII.
While zwitterionic PC lipids are predominant in lipoproteins, an overall
negatively charged vesicle surface was chosen to facilitate comparison
to ApoCIII binding to anionic SDS micelles and PA was used because
it is known to induce tight binding of amphipathic helices such as α-
synuclein [24]. Secondary structural transformation from disordered
to α-helical conformation was monitored via circular dichroism (CD)
spectroscopy. Polypeptide conformational changes upon vesicle associ-
ation alsowere corroborated by intrinsic Trp ﬂuorescence. Trp emission
properties are highly sensitive to local environment and therefore are
excellent probes of protein–lipid interactions [24–30]. There are three
native Trp residues located at positions 42, 54, and 65 (Fig. 1B). To
delineate residue-speciﬁc behavior, three ApoCIII variants were gener-
ated where all but one of the Trp sidechains were substituted by Phe
(W42 (W54F/W65F), W54 (W42F/W65F), W65 (W42F/W54F)). W42
andW54 report on helices 3 and 4, respectively, whereasW65 is located
outside and immediately after helix 4 (Fig. 1B). Interestingly,W54 in the
middle of helix 4 might constitute a hinge, breaking the helix as
suggested by NMR secondary structural data; however, no bend is
evident in the three dimensional structure (PDB ID: 2JQ3). The effect
of Trp mutations on global secondary structural changes was evaluated
by CD spectroscopy. Changes in sidechain mobility and polarity of local
environment of individual Trp sites in the presence of vesicles were
measured by time-resolved anisotropy and steady-state ﬂuorescence
spectroscopy, respectively. Using brominated lipids, bilayer penetration
depths ofW42,W54, andW65 sidechainswere determined. Finally, the
results are discussed by comparing trends in Trp ﬂuorescence proper-
ties for vesicle- vs. micelle-bound ApoCIII.
2. Materials and methods
2.1. Materials
Phospholipids (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphate (PA),
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (PC), 1-palmitoyl-
2-(6,7-dibromo)stearoyl-sn-glycero-3-phosphocholine (Br6–7PC), 1-
palmitoyl-2-(9,10-dibromo)stearoyl-sn-glycero-3-phosphocholine
(Br9–10PC) and 1-palmitoyl-2-(11,12-dibromo)stearoyl-sn-glycero-3-
phosphocholine (Br11–12PC)) were purchased from Avanti Polar Lipids
(Alabaster, AL) and used as received. N-acetyl-tryptophanamide
(NATA), tris(hydroxymethyl)aminomethane (Tris), and sodium
dodecyl sulfate (SDS)were obtained from Sigma-Aldrich (St. Louis, MO).
2.2. Recombinant protein expression and puriﬁcation
The ApoCIII expression plasmid (pET23b) was provided by Philippa
Talmud (University College London Medical School, London, UK) [14].
The wild-type (WT) protein construct contains eight additional C-
terminal residues including a His-tag (Leu-Glu-(His)6) for afﬁnity
puriﬁcation. Single Trp-containing ApoCIII mutants (W54F/W65F
(W42), W42F/W65F (W54), W42F/W54F (W65)) were generated by
site directed mutagenesis (QuikChange kit, Strategene). All proteins
were transformed into Escherichia coli BL21(DE3) pLysS competent
cells (Invitrogen), expressed, and puriﬁed as previously described
[31] with one modiﬁcation. After centrifugation of the cell homogenate
(30 min, 31,000 ×g), the supernatant was incubated overnight at 4 °C
with 10 mL (bed volume) of pre-equilibrated Talon cobalt resin
(Clontech). The cobalt resin was then washedwith the 100mL of buffer
(100 mM NaPi, 100 mM NaCl, 8 M urea, pH 7.4) and eluted with an
additional 50 mL of buffer containing 300 mM imidazole.
Protein concentration was determined using a molar extinction
coefﬁcient (ε) estimated on the basis of amino-acid content using
the ProtParam Program: ε280nm = 19,480 M−1 cm−1 for WT and
8480M−1 cm−1 forW42,W54, andW65. The purity of protein samples
was assessed by NuPAGE SDS-PAGE gels on Xcell SureLock Mini-Cell
(Invitrogen). Gels were stained with Coomassie blue R250 and
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were conﬁrmed by electrospray ionization mass spectrometry
(Biochemistry Core Facility, NHLBI). WT: 9829 (9829.79 calcd), W42:
9751 (9751.7 calcd), W54: 9751 (9751.7 calcd), W65: 9751 (9751.7
calcd).We also notedmasses corresponding to the incomplete cleavage
of the N-terminal Met residue (+131 amu). All puriﬁed proteins were
concentrated using a YM-3 ﬁlter (MWCO 3kD, Millipore) and stored at
−80 °C.
2.3. Phospholipid vesicle preparation
Phospholipid vesicles were made from a 1:1 molar ratio of PC and
PA. For Trp penetration depth experiments, brominated-PC lipids
(BrPC: Br6–7PC, Br9–10PC, and Br11–12PC) were added to a ﬁnal concen-
tration of 30% while maintaining an overall 1:1 molar ratio of PA and
PC. Chloroform solutions of 1:1 PC and PA (PC/PA) or 1:1 PC/BrPC and
PA were dried under a nitrogen stream for 20 min followed by vacuum
desiccation for 45 min to ensure complete removal of organic solvent.
Dried samples were then resuspended in 10 mM Tris, 100 mM NaCl
buffer, pH 7.4 to a ﬁnal concentration of 5 mg/mL by bath sonication
for 5–10 min. Vesicles were prepared via ultrasonication in a water
bath (45 min, 50% duty cycle, microtip limit, Branson 450 Soniﬁer).
Vesicle solutions were diluted to a ﬁnal concentration of 2.5 mg/mL,
equilibrated overnight (14–24 h) at 37 °C, and prepared the day before
each experiment. Average vesicle hydrodynamic radiuswas determined
to be 45–55 nm by dynamic light scattering (Wyatt DynaPro NanoStar;
ﬁfty 5-s acquisitions, 25 °C).
2.4. Steady-state spectroscopic measurements
Spectroscopic measurements were made as follows: absorption,
Cary 300 Bio spectrophotometer; CD, Jasco J-715 spectropolarimeter
(198–260, 1 nm steps, 1 nm bandwidth, 0.5 s integration time, and 50
nm/min, 1 mmquartz cuvette), and luminescence, Fluorolog-3 spectro-
ﬂuorometer (λex = 295 nm, λobs = 300–500 nm, 0.25 s integration
time, 1 and 2 nm excitation and emission slit widths, respectively). All
measurementswere collected at 25 °C using temperature controlled cu-
vette holders except for absorbance experiments. Prior to all experi-
ments, ApoCIII was exchanged into ﬁltered (0.22 μm membrane pore
size) buffer (10 mM Tris, 100 mM NaCl, pH 7.4) using a PD-10 column
(GE Healthcare). For all spectra measured in the presence of vesicles,
background scanswere collected and subtracted. Prior tomeasurement,
protein-vesicle solutions (5 μM) were incubated at RT for at least
30 min. For Trp quenching experiments, a phospholipid-to-protein
molar ratio (L/P) of 400 (2 mM phospholipid) was used.
2.5. Time-resolved ﬂuorescence anisotropy
Tryptophan ﬂuorescence anisotropy decay kinetics were measured
using the fourth harmonic (292 nm) of a regeneratively-ampliﬁed fem-
tosecond Ti:sapphire (Clark-MXR) pumped optical parametric ampliﬁer
laser (Light Conversion) as an excitation source (80–120 μW, 1 kHz) and
a picosecond streak camera (Hamamatsu C5680) in photon counting
mode for detection. Tryptophan emission (325–400 nm) was selected
through edge (REF-325) and short-pass (UG-11) ﬁlters (CVI Laser).
Polarized Trp excited state decays (I⊥(t) and I//(t)) were measured
simultaneously with an optical ﬁber array and corrected for differences
in collection efﬁciency of vertically and horizontally polarized light
using the Trp model complex, N-acetyl-tryptophanamide (NATA).
Prior to measurement, protein samples (5 μM in 10 mM Tris,
100 mM NaCl buffer, pH 7.4) and samples containing vesicles (L/P =
400, 2 mM POPA:POPC) were deoxygenated on a Schlenk line by 3
sets of 5 repeated evacuation/Ar ﬁll cycles over 30 min. A collection
temperature of 25 °C was maintained using a temperature controlled
cuvette holder and a circulating water bath. To ensure good signal to
noise, all kinetics data were collected such that at least 10,000 countswere achieved in the highest channel for each polarization. Our instru-
ment response time is ~150 ps. Steady-state ﬂuorescence spectra
were measured before and after laser experiments to verify minimal
photodamage.
2.6. Data analysis
2.6.1. Circular dichroism
Mean residue ellipticity, [Θ] (deg cm2 dmol−1), was calculated
according to the equation, ½Θ ¼ 100θclN where θ is the measured ellipticity
(mdeg), c is the sample concentration (mM), l is the path length (cm),
and N is the number of amino acids. Percent α-helicity (100fhelix) was
calculated using the equation [32] f helix ¼ ð½Θ222−½ΘcoilÞð½Θhelix−½ΘcoilÞ, where ½Θhelix ¼
−40;000ð1− 2:5n Þ þ 100T and [Θ]coil=640− 45T, T is the temperature
in °C, and n is the number of amino acids.
2.6.2. Membrane binding equilibrium
Membrane binding data for WT and ApoCIII variants were modeled
according to the following two-state equilibrium, a partitioning of the
polypeptide between the free and membrane-bound state [33]:
P f ↔
Kappp
Pb K
app
p ¼
xbp
c fp
ð1Þ
where Pf and Pb are the free and bound protein states, respectively, Kpapp is
the apparent partition constant, xpb is the mole fraction of bound protein,
and cpf is the concentration of the free protein. The mole fraction of
bound protein is given by xbp ¼
cbp
coL
where cpb is the total bound protein
and cLo is the total lipid concentration. Substitution of xpb and cpf = cpo−
cp
b where cpo is the total protein concentration into Eq. (1) yields:
Kappp ¼
cbp
cop−cbp
 
coL
: ð2Þ
Since CD and ﬂuorescence data (Δ[Θ]222nm andΔI335nm, respectively)
are proportional to c
b
p
cop
, Eq. (2) can be solved for an equation amenable to
data ﬁtting:
Θ½  ¼ K
app
p c
o
L
1þ Kappp coL
: ð3Þ
Because only lipids in the outer monolayer are available for protein
association, Kpapp is replaced by 0.6 Kpapp. Fits to data (n ≥ 3 independent
titrations per protein) were performed using the IGOR PRO 6.3
(Wavemetrics).
2.6.3. Time-resolved anisotropy
Fluorescence anisotropy decays were calculated according to:
r tð Þ ¼ I== tð Þ−α tð ÞI⊥ tð Þ
I== tð Þ þ 2α tð ÞI⊥ tð Þ ð4Þ
where r(t) is the apparent anisotropy at time t andα(t) is the ratio of the
polarized emission, I==ðtÞI⊥ðtÞ , of NATA. Anisotropy decays were analyzed
according to the following equation,
r tð Þ ¼ roe −t=ϕcð Þ þ r∞ ð5Þ
where ro and r∞are the apparent anisotropy at t=0 and∞ andϕcare the
rotational correlation time resulting from depolarization. Kinetics were
ﬁt using Levenberg–Marquardt least-squares minimization algorithm
implemented in a Matlab (The Mathworks Inc.) program (KINFIT)
written by Jay R. Winkler (California Institute of Technology).
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Trp emission spectra were modeled using a log normal distribution
function [29,34] and IGOR PRO 6.3 (Wavemetrics).
I λð Þ ¼ I0 exp − ln 2ð Þln2 ρð Þ ln
2 1þ λ−λmaxð Þ ρ
2−1
 
ρΓ
 !" #
ð6Þ
λmax is thewavelength atwhichmaximum intensity is observed, I0 is
the intensity at λmax, and Г is the full width at half maximum of the
peak. The ﬁt parameter ρ describes the asymmetry of the distribution.
The parameter ρ ranges from 1.3 to 1.5.
2.6.5. Trp penetration depth
A mean Trp depth was obtained by Gaussian distribution analysis
using Eq. (7) and IGOR PRO 6.3 (Wavemetrics) [35].
ln
F0
FBr
¼ S
σ
ﬃﬃﬃﬃﬃﬃ
2π
p exp − x−xmð Þ
2
2σ2
" #
ð7Þ
F0 and FBr are the measured Trp intensities in the absence and
presence of Br-PC, respectively, and xm (mean depth), σ (dispersion),
and S (area) describe the distribution of the quenched population.
3. Results and discussion
3.1. ApoCIII adopts α-helical structure upon vesicle binding
WT ApoCIII contains three tryptophan residues at positions 42, 54,
and 65 (Fig. 1). To monitor site-speciﬁc interactions of ApoCIII with
phospholipid vesicles, single-Trp containing variants, W42, W54, and
W65, were produced and themutational effects on secondary structure
formation upon vesicle bindingwere assessed byCD spectroscopy. Fig. 2
shows average values (n ≥ 3 independent measurements) of mean
residue ellipticity at 222 nm ([Θ]222nm) for WT, W42, W54, and W65
ApoCIII as a function of lipid concentration. Representative CD spectra
for the W54 mutant in the presence of increasing vesicles are also
provided (Fig. 2 inset). In buffer (5 μM ApoCIII, 10 mM Tris, 100 mM
NaCl, pH 7.4), CD spectra for WT ApoCIII and variants exhibit a global
minimum at 200 nm reﬂecting random coil conformations. Upon the
addition of phospholipid vesicles (0–2 mM PC/PA, diameter ~100 nm)Fig. 2.Mean residue ellipticity ([Θ]) at 222 nm for WT (black) and single-Trp containing
ApoCIII variants (W42 (red),W54 (green), andW65 (blue)) as a function of lipid concen-
tration (5 μMprotein and PC/PAvesicles in10mMTris, 100mMNaCl buffer, pH7.4, 25 °C).
Error bars represent the standard deviation of the mean for n ≥ 3 independent measure-
ments. Fits (solid lines) to a two-state partition equilibrium model yield partition
constants with their associated 68% conﬁdence intervals: WT (2.5 ± 1.3 × 104 M−1),
W42 (1.9 ± 1.0 × 104 M−1), W54 (1.2 ± 0.3 × 104 M−1), and W65 (9.0 ±
3.6 × 103 M−1). (Inset) Representative far UV CD of theW54 variant (5 μM) as a function
of added lipid vesicles.proteins undergo a conformational change as evidenced by increases
in [Θ]222nm. The presence of an isodichroic point at 204 nm is consistent
with a two-state transition between random coil and α-helical confor-
mations. At saturating concentrations of vesicles (L/P N 500), [Θ]222nm
values are approximately −18,300 to −21,800 deg cm2 dmol−1
corresponding to 50–59%α-helical contentwith the Trp variants having
slightly higher ellipticity values (Fig. 2).
Apparent membrane partition constants (Kpapp) for WT ApoCIII and
variants were determined by ﬁtting CD data ([Θ]222nm) to a
membrane-partition model [33]. Kpapp for WT ApoCIII is ~3 × 104 M−1.
This value is nearly one order ofmagnitude higher than that determined
for thewell characterized Parkinson's disease related andmembrane as-
sociating protein α-synuclein (~4 × 103 M−1) under similar solution
conditions [36]. The high afﬁnity of ApoCIII for the membrane is not
surprising given that it has been shown to displace both ApoE [37]
and ApoAII [38] from lipoproteins and is proposed to block the lipopro-
tein lipase activating ApoCII from the lipoprotein surface [10,11]. Small
differences in Kpapp values were seen between WT and variants
(WT ≈W42 N W54 N W65), indicating subtle effects of one or more
of the three Trp sites in ApoCIII membrane binding and secondary
structural formation. Of the three Trp residues, only W42 is invariant
in ApoCIII, and interestingly, the W42 construct shows the smallest
deviation fromWT.
3.2. Site-speciﬁc tryptophan probes of ApoCIII at the membrane interface
Steady-state Trp ﬂuorescence and time-resolved anisotropy of
ApoCIII variants were measured to evaluate the site-speciﬁc interac-
tions ofW42,W54, andW65withmembranes. Fig. 3 shows representa-
tive steady-state emission spectra for ApoCIII (5 μM) in the absence and
presence of PC/PA vesicles (0–2.0 mM in 10 mM Tris, 100 mM NaCl
buffer, pH 7.4, 25 °C). In buffer, the ﬂuorescence spectra for all proteins
have similar peak positions at maximum intensity (λmax) consistent
with water-exposed Trp side chains (bλmax N= 344, 340, and 344 nm
for W42, W54, and W65, respectively). Upon vesicle addition, spectral
blue shifts and increases in integrated intensity (I) were observed for
all variants suggesting less polar environments and reduced mobilities
for all the Trp sidechains. The largest changes in spectral blue-shift
were exhibited byW54 indicating that it resides in the most hydropho-
bic surrounding followed byW42 andW65. Titration for theWTprotein
is also shown for comparison. The WT spectral features are adequately
described by the addition of the three individual Trp data, indicating
that despite their sequence proximity, the Trp spectra are not correlated
(i.e. energy transfer).
With a large spectral blue shift (Δλmax= 17 nm, bλmax N=323 nm),
reminiscent of integral membrane proteins (E.coli outer membrane
protein A: Δλmax = 25–28 nm, dimyristoylphosphatidylcholine
(DMPC) [39,40]), W54 likely embeds in the hydrophobic hydrocarbon
region. Conversely, modest changes in W42 and W65 (Δλmax = 10
and 7 nm, respectively, bλmax N= 334 and 337 nm, respectively) sug-
gest these sitesmay be closer to the partially hydrated lipid head groups.
While not a distinguishing measure of site-speciﬁc environments,
Δλmax for the WT protein is 10 nm (bλmax N = 332 nm) which is
similar to early work on ApoCIII binding to DMPC bilamellar vesicles
(Δλmax = 11.5 nm [41]).
While increases in I are observed for all sites, small relative changes
(W65 NW42 NW54) likely reﬂect differences in sidechainmobility and/
or proximity to local charges [42]. For example, the close interaction of
W54 with D52, the nearest negatively charged residue, would result
in a quantum yield decrease while the close interactions of W42 and
W65 with the POPC headgroup trimethylammonium cation would
result in quantum yield increase. Fig. 3 insets show changes in I at
335 nm as a function of lipid concentration for W42, W54, and W65.
While each Trp residue resides in different local environment,
all the data can be sufﬁciently ﬁt with one global Kpapp value (6.9 ±
0.9 × 103 M−1). The Kpapp value obtained from Trp data is reduced
Fig. 3. Representative steady-state emission spectra for W42, W54, W65, and WT (top to
bottom) ApoCIII (5 μM) in the presence of lipid vesicles (0–2.0 mM PC/PA in 10 mM Tris,
100 mM NaCl buffer, pH 7.4, 25 °C). Lipid vesicle backgrounds were subtracted for each
vesicle concentration. Color intensity from light-to-dark indicates increasing lipid vesicle
concentration. (Insets) Trp intensity at 335 nmplotted as a function of lipid concentration.
All data were globally ﬁt (solid lines) to a two-state partition equilibriummodel to yield a
partition constant of 6.9 ± 0.9 × 103 M−1. Error bars represent the standard deviation of
the mean for n ≥ 3 independent measurements.
Fig. 4. Time-resolved anisotropy decays for W42 (red), W54 (green), and W65 (blue)
ApoCIII in the absence (5 μM in 10 mM Tris, 100 mM NaCl buffer, pH 7.4, 25 °C, top),
in the presence of SDS micelles (1.8 mM, middle) and phospholipid vesicles (2.0 mM
PC/PA, bottom). Solid black lines represent single exponential ﬁts. The lipid data were
not ﬁt since insigniﬁcant decay occurred on the measurement timescale.
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adequately ﬁt to one partition constant. Both W54 and W65 bind
more weakly than W42 which is comparable to WT. It is interesting
that secondary structural formation appears to be more sensitive to
mutational changes than that of the site-speciﬁc probes. Perhaps, this
is a reﬂection that Trp spectroscopic changes report on the partitioning
of the sidechain fromwater to bilayer and helical content is muchmore
inﬂuenced by the mutations of native Trp to Phe residues.
Measurements of time-resolved anisotropy conﬁrm decreases in
rotational motion of the Trp sidechains. As shown in Fig. 4, all ApoCIII
variants in buffer exhibit small initial anisotropies (ro = 0.06, instru-
ment response time ~150 ps) with ns rotational correlation times
(ϕc = 1.1–2 ns) and zero residual anisotropy (r∞) consistent with
solvent-exposed and freely rotating Trp sidechains. Slight differenceswere seen upon the addition of SDS micelles (1.8 mM); however, in
the presence of vesicles, ro, r∞, and ϕc increase reﬂecting vesicle binding
and restriction in rotational motion. Speciﬁcally, all sites exhibit
minimal decay from ro on the timescale of the ﬂuorescence measure-
ment (b20 ns). Modest site dependent increases in ro are consistent
with steady-state quantum yields (W65 N W42 N W54) conﬁrming
that decreases in rotationalmotion of the ﬂuorophores uponmembrane
binding is indeed at least partially responsible for quantum yield
increases. Interestingly, this behavior is the reverse of the spectral
blue-shift trend (W54 NW42 NW65) presented above, indicating that
despite being in amore hydrophobic environment,W54 ismoremobile
thanW42 andW65.W54 is the least conserved Trp in ApoCIII, with Phe,
Leu, andMet substitutions seen in other species, suggesting that residue
54 contributes to non-speciﬁc hydrophobic interactions, which is con-
sistent with the mobility data.
3.3. Comparison of vesicle- vs. micelle-bound ApoCIII by Trp ﬂuorescence
Apolipoproteins bind to lipoproteins that vary in size; a feature
that likely requires protein conformational rearrangements at the
membrane interface. To begin to assess ApoCIII local structure at differ-
ent membrane interfaces, we compared the site-speciﬁc interactions
of ApoCIII with phospholipid vesicles vs. SDS micelles. Fig. 5 shows
steady-state Trp ﬂuorescence for ApoCIII variants (5 μM in 10 mM
Tris, 100mMNaCl buffer, pH 7.4, 25 °C) in the presence of phospholipid
vesicles (2 mM PC/PA) and SDS micelles (1.8 mM; critical micelle
concentration = 1.33 mM for 100 mM NaCl at 25 °C). Signiﬁcant
spectral differences in vesicle- and SDS micelle-bound conformations
are observed.
Unlike the vesicle case, quantum yield decreases for W42 and W54
in the presence of SDS micelles, implying that Trp sidechains likely
retain signiﬁcant mobility. Indeed, time-resolved anisotropy measure-
ments of SDS-micelles bound ApoCIII variants conﬁrm minimal
deviations in local mobility as compared to proteins in buffer alone
(Fig. 4 middle panel). However, quantum yield decreases could also
reﬂect interactions with the negatively charged sulfonate group of SDS
[42].
In addition, spectral analysis using log-normal distribution ﬁts [29]
reveals smaller changes in λmax for all sites in the presence of SDS
micelles with the exception of W54 (Fig. 6). The solid line in Fig. 6 is
the reported ﬁt [29] to the full width at half maximum (Γ) and λmax of
Fig. 5. Comparison of SDS micelle- and vesicle-bound ApoCIII. Steady-state emission
spectra for W42, W54, and W65 ApoCIII variants (top to bottom) in buffer (10 mM Tris,
100 mM NaCl, pH 7.4) (black) and in the presence of SDS micelles (1.8 mM; blue) and
phospholipid vesicles (2.0 mM PC/PA; red). (Inset) Corresponding CD spectra for each
variant in the different solution conditions. Averages of independently measured spectra
(n ≥ 3) are shown.
Fig. 6. Position of spectral maximum (λmax) vs. spectral width (Γ) plot extracted from log-
normal ﬁts of Trp emission spectra of single-Trp ApoCIII variants in buffer (10 mM Tris,
100mMNaCl, pH7.4) (open circles,W42andW65points overlapped) and in thepresence
of SDSmicelles (1.8mM; solid circles) and phospholipid vesicles (2.0mMPC/PA; squares).
Error bars represent the standard deviation of the mean for n ≥ 3 independent measure-
ments. The gray line is the reported linear relationship for N-acetyl-tryptophanamide in
solvents with varying polarity [29].
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Smaller values of λmax would correspond to more hydrophobic local
environment, and the region above the line would indicate conforma-
tional heterogeneity of speciﬁc Trp residues.
Spectral analysis revealed opposing effects in the presence of
SDS micelles compared to vesicles. While W54 experiences a more
protected environment in the presence of SDS micelles (λmax = 319
vs. 323 nm for micelle- vs. vesicle-bound, respectively), both W42 and
W65 are in a more polar surrounding with a λmax closer to that
measured in buffer alone. Interestingly, W54 appears to be consistently
in a more hydrophobic environment compared to the other two sites
even in buffer solution alone, suggesting that this residue is solvent
protected, perhaps residing in a hydrophobic cluster. The widths for
micelle-bound proteins show greater conformational heterogeneity
for all three sites. These differences strongly support local structural
differences in protein–lipid vs. protein–detergent interactions. While
key membrane interaction sites could still be preserved, observed Trp
spectral differences indicate that local changes have occurred in helices
3 and 4, implying that relative length and/or arrangements of the α-helical regions may be different when it is vesicle-bound. The differ-
ences in α-helical content observed for vesicle- vs. micelle-bound
ApoCIII (Fig. 5 inset) are supportive of this assertion and changes in
the N-terminal region are also possible. Consistently, the helical content
is increased ~16–26% in the presence of vesicles. While SDS can induce
helical structure in peptides and proteins, it can also disrupt the native
fold of membrane proteins [43,44], which could explain the differences.
Though SDSwas chosen here in order to compare to the NMR structure,
other milder detergents might serve as better membrane mimics for
future studies.
3.4. Site-speciﬁc membrane insertion of ApoCIII determined by Trp-Br
quenching
To determine the location ofW42,W54, andW65within the bilayer,
we measured the steady-state ﬂuorescence of ApoCIII variants in the
absence and presence of vesicles containing phospholipids labeled
with the heavy atom ﬂuorescence quencher, bromine, at different
positions in the lipid acyl chain. A structure of the labeled PC
phospholipids used in this study (Br6–7PC, Br9–10PC, and Br11–12PC)
with positions of the bromines indicated (~6, 8.3, and 11 Å from bilayer
center [45]) is provided in Fig. 7A. Fig. 7B shows the relative quenching
of W42, W54, and W65 steady-state ﬂuorescence (5 μM in 10 mM Tris,
100 mM NaCl buffer, pH 7.4, 25 °C) in the presence of 2.0 mM PC/PA
vesicles containing either 30 mol% Br6–7PC, Br9–10PC, or Br11–12PC. The
logarithm of the ratio of the integrated steady-state Trp emission
(325–400 nm) measured in the absence (F0) and presence (FBr) of the
brominated lipids is plotted as a function of distance from the bilayer
center. The relative insertion depths of the individual Trp sidechains
were obtained by distribution analysis [35].
The presence of brominated lipids causes decreases in W42,
W54, and W65 ﬂuorescence providing conclusive evidence that
all sites are directly interacting with the bilayer. W54 ﬂuorescence
was quenched comparably by all three Br sites andW42 was quenched
more by Br9–10 and Br11–12. A reciprocal trend of quenching was exhib-
ited by W65 as a function of penetration depth. From distribution ﬁt
analysis [35], it is revealed that W54 is the most embedded followed
by W42 then W65. Average mean depths of 8.4 ± 0.2 Å, 10.7 ± 1.6 Å,
and 15 ± 3 Å were obtained for W54, W42, and W65 (n = 4). It
is clear that W65 has a preference for locations closer to the lipid
head groups. There are limitations in using steady-state data alone
and the precision of the depth determination can be improved [46].
Nevertheless, the relative Trp penetration depths are in accord with
Fig. 7. (A) Structure of PC shown with positions of bromines (black circles) and their
corresponding distances from the bilayer center indicated above. (B) Steady-state
Trp ﬂuorescence of single-Trp ApoCIII variants (5 μM) in the presence of PC/PA (F0) and
PC/PA vesicles containing 30% brominated PC lipids (FBr). Solid lines are ﬁts to distribution
analysis using mean values for n = 4 independent measurements. Error bars represent
standard deviations. Location of the three different Br-sites is denoted by gray lines.
(C) Schematic representation of an amphipathic helix that is consistent with the Trp-Br
data present in panel B. The helix starts at residue 40 and ends at residue 66. The view is
looking down the helix from the N-terminus. The Trp residues used in this study are
colored red, green, and blue for W42, W54, and W65, respectively. Acidic and basic
residues are pink and cyan, respectively. Putative interfacial regions are also indicated.
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gle, long amphipathic helix from residue 40 to 66 containing the three
tryptophan residues [14,19], and a model structure of the predicted
helix shows Trp penetration depths in agreement with experiment
(Fig. 7C). This suggests that the break between helices 3 and 4 in the
NMR micelle-bound structure may have been due to the highly curved
SDSmicellar surface, and that lack of the break for vesicle-boundApoCIII
may account for at least part of the increased helicity measured by CD
(Fig. 5). While this model is presented to visualize how a helix contain-
ing these residues might look, it is not deﬁnitive and other conforma-
tions are possible on the membrane.
4. Conclusion
Wehave investigated the phospholipid binding properties of ApoCIII
using a variety of complementary spectroscopic techniques. Under-
standing of apolipoprotein–phospholipid interaction is important forthe mechanism of folding and function of lipoproteins. Speciﬁcally, we
have substituted two of the three native Trp residues with Phe in
ApoCIII in order to have single ﬂuorescent probes of membrane
association at three speciﬁc sites,W42,W54, andW65. Secondary struc-
ture formation was evaluated using CD spectroscopy and membrane
binding afﬁnity was determined. Despite the conservative mutation,
Trp-to-Phe substitutions had subtle effects on the structural change of
ApoCIII helical formation (Fig. 2). Our data would suggest that W42
may be the most important for protein–lipid interaction as when it is
substituted by Phe small but signiﬁcant deviations from the WT are
apparent.
Molecular level insights including polarity of local environment,
sidechain mobility, and bilayer penetration depth were obtained thru
steady-state and time-resolved Trp ﬂuorescence measurements.
All three Trp sites directly interact with the bilayer and experience
distinct membrane environments with W54 inserting the deepest
into the lipid hydrocarbon interior followed by W42 and W65. The
relative Trp penetration depths are consistent with their respective
λmax values which report on the polarity of local environment
(W65 N W42 N W54). Interestingly, a reverse trend was observed for
sidechainmobility (W54 NW42 NW65) based on time-resolved anisot-
ropymeasurements, suggesting that despite being in amore hydropho-
bic, hydrocarbon interior region, W54 retains greater mobility than the
other sites. Taken together, we propose that a single C-terminal extend-
ed helical conformation can be adopted by ApoCIII in the presence of
vesicles in contrast to the two helices in the micelle-bound struc-
ture [16]. We suggest that the break between amphipathic helices 3
and 4 may be a result of the highly curved micelle shape. Our ﬁnding
that ApoCIII adopts distinct local conformations when bound to differ-
entmembranemimics indicates that ApoCIII structural changes depend
on particle size and lipid composition, acting as natural regulators of
binding and exchange [47].Transparency Document
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